Informed-money record

IMVT · Immunovant, Inc.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

Bearish filings

Named actors

Disclosed $ (bull / bear)

$350.0M / $31.4M

Recent disclosures

25 of 71 in the window · linked to source

Date	Who	What	Disclosed $	Receipt
2026-08-28	Director Pande Atul	sold	$65K	SEC ↗
2026-08-20	Chief Operating Officer Gloria Melanie	sold	$135K	SEC ↗
2026-08-14	5%+ holder (13G) — reduced stake Deep Track Capital, LP	reduced its stake (13D/G amendment)	—	SEC ↗
2026-07-24	Director Pande Atul	sold	$60K	SEC ↗
2026-07-23	Chief Financial Officer Girao Tiago	sold	$263K	SEC ↗

46 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →

Dispute or correct this record

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals